Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-26

Clinical Trial Update: Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing short-term effects of liraglutide versus vildagliptine on insulin secretion and insulin sensitivity in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)
  • vildagliptine (vildagliptine)

Snippet

Sponsor: Yaounde Central Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED